Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing toxic thyroid adenoma: a cost-effectiveness analysis.

Gwenaelle M Vidal-Trecan1, James E Stahl, Isabelle Durand-Zaleski

  • 1Departement de sante publique, CHU Cochin Port Royal, Assistance Publique-Hopitaux de Paris, Universite Rene Descartes, Paris, France. gwenaelle.Vidal-Trecan@cochin.univ-paris5.fr

European Journal of Endocrinology
|March 13, 2002
PubMed
Summary

For toxic thyroid adenoma, surgery is the most cost-effective treatment for most patients. Radioactive iodine (RAI) and antithyroid drugs (ATDs) may be considered for specific patient groups based on age and cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pines and Needles: Experience of an Acupuncture Practice at an Academic Medical Center in Rural New England.

Medical acupuncture·2026
Same author

Cost Analysis of Mobile Phone Teledentistry in Dental Treatment Planning in Pediatric Care in the United Arab Emirates.

International journal of clinical pediatric dentistry·2026
Same author

Impact of an intervention standardizing the perinatal management of extremely preterm infants on the child's survival without severe morbidity: a stepped-wedge cluster-randomized trial (PREMEX study).

BMC pregnancy and childbirth·2026
Same author

Impact of first-trimester preeclampsia screening on perinatal and maternal morbidity: the RANSPRE open multicenter randomized trial.

BMC pregnancy and childbirth·2026
Same author

Prevention of secondary infections by interferon-gamma in ICU-acquired sustained immune suppression in France: study protocol of the PLATINIUM randomised trial.

BMJ open·2026
Same author

Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy.

Archives of cardiovascular diseases·2026

Area of Science:

  • Endocrinology
  • Health Economics
  • Decision Analysis

Background:

  • Toxic thyroid adenoma presents a therapeutic challenge with multiple treatment options.
  • Evaluating the cost-effectiveness of these strategies is crucial for optimal patient care and resource allocation.

Purpose of the Study:

  • To compare the cost-effectiveness of different therapeutic strategies for toxic thyroid adenoma.
  • To identify the most economically viable treatment options based on patient characteristics and outcomes.

Main Methods:

  • A decision analytic model was employed to assess strategies including surgery, radioactive iodine (RAI), and antithyroid drugs (ATDs).
  • Quality-adjusted life years (QALYs) were used to measure outcomes, with data derived from a systematic literature review (1966-2000).

Related Experiment Videos

  • Sensitivity analyses were conducted to evaluate the impact of variations in cost, efficacy, and patient factors.

    • Main Results:

    • For a 40-year-old woman, surgery was the most effective and least costly strategy (Euro 1391).
    • Radioactive iodine (RAI) became more cost-effective for women over 72 years old.
    • Antithyroid drug-radioactive iodine (ATD-RAI) was the most expensive strategy but could be cost-effective for 85-year-old women under specific conditions.

    Conclusions:

    • The optimal therapy for toxic thyroid adenoma depends on individual patient factors such as age, surgical mortality risk, and treatment costs.
    • Patient preference should also be a key consideration in the therapeutic decision-making process.